World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
44830
World Ranking
12441
National Ranking
6371

Overview

David H. Vesole is affiliated with Rutgers, The State University of New Jersey in the United States. Their research primarily focuses on the field of medicine, with significant contributions to hematology, molecular biology, oncology, genetics, and pathology and forensic medicine.

The scientist's work covers a broad array of topics, emphasizing multiple myeloma research and treatments, protein degradation and inhibitors, chronic lymphocytic leukemia research, CAR-T cell therapy research, peptidase inhibition and analysis, chronic myeloid leukemia treatments, and hematopoietic stem cell transplantation.

David H. Vesole has published extensively in various scientific journals. Their frequent publication venues include the following:

  • Blood
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Cancer
  • Transplantation and Cellular Therapy

Several recent publications illustrate the areas of their research interest and collaboration, including:

  • Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM). (2020, Journal of Clinical Oncology)
  • Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma. (2020, Cancer)
  • KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer. (2020, Kidney International)
  • Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. (2020, Leukemia)
  • Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT). (2022, Blood Cancer Journal)

Collaboration with frequent co-authors appears to be a significant element of their research activity. Frequent co-authors include:

  • Noa Biran
  • David S. Siegel
  • Harsh Parmar
  • Parameswaran Hari
  • Pooja Phull

Best Publications

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

    Joan BladÉ;Diana Samson;Donna Reece;Jane Apperley

  • Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

    Andrew J Ullmann;Jeffrey H Lipton;David H Vesole;Pranatharthi Chandrasekar

  • Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

    S Vincent Rajkumar;Susanna Jacobus;Natalie S Callander;Rafael Fonseca

  • Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group

    S. Vincent Rajkumar;Emily Blood;David Vesole;Rafael Fonseca

  • Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

    Paul G. Richardson;Edie Weller;Sagar Lonial;Andrzej J. Jakubowiak

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

    Jo Anne H. Van Burik;Voravit Ratanatharathorn;Daniel E. Stepan;Carole B. Miller

  • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

    Bart Barlogie;Sundar Jagannath;David H. Vesole;Sally Naucke

  • Graft-versus-myeloma effect: proof of principle

    Guido Tricot;David H. Vesole;Sundar Jagannath;Jennifer Hilton

  • Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

    B. Barlogie;S. Jagannath;K.R. Desikan;S. Mattox

  • The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

    Neal Flomenberg;Steven M. Devine;John F. DiPersio;Jane L. Liesveld

  • Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients

    Guido Tricot;Sundar Jagannath;David Vesole;Jean Nelson

  • Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

    Steven M. Devine;Neal Flomenberg;David H. Vesole;Jane Liesveld

  • Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities

    Guido Tricot;Bart Barlogie;Sundar Jagannath;Dwayne Bracy

  • Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

    Joseph T. Beck;Su-Ming Hsu;John Wijdenes;Regis Bataille

  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

    Radek Spisek;Anna Charalambous;Amitabha Mazumder;David H. Vesole

  • International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    Sv Rajkumar;Jl Harousseau;B Durie;Kc Anderson

Frequent Co-Authors

David S. Siegel
David S. Siegel Hackensack University Medical Center
Parameswaran Hari
Parameswaran Hari Medical College of Wisconsin
Sundar Jagannath
Sundar Jagannath Icahn School of Medicine at Mount Sinai
Sagar Lonial
Sagar Lonial Emory University
Paul G. Richardson
Paul G. Richardson Harvard University
Guido Tricot
Guido Tricot University of Iowa
Ravi Vij
Ravi Vij Washington University in St. Louis
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Nikhil C. Munshi
Nikhil C. Munshi Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the healthcare field but want to explore alternative pathways or enhance your credentials, online degrees offer flexible and affordable options. Programs like the cheapest online mha programs are ideal for those aiming for leadership or administrative positions within hospitals, clinics, or public health organizations.

Nursing professionals seeking advanced clinical roles might consider the cheapest dnp online programs, which prepare graduates for top practice and leadership jobs. Pharmacists and pharmacy technicians can further their expertise with online pharm d programs, opening doors to research, teaching, or specialized practice.

For those interested in the digital side of healthcare, a him bachelor's degree online can lead to in-demand roles managing patient data, health IT systems, and regulatory compliance. Exploring these online degrees can expand your career options, improve your earning potential, and allow you to make a significant impact in the evolving healthcare landscape.

Best Scientists Citing David H. Vesole

Trending Scientists

Recently Published Articles